A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will ...

Since the US Food and Drug Administration (FDA) implemented a ban on ‘compounded’ versions of Wegovy on 22 May, new ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.

NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...

RELATED: Ozempic and Wegovy May Have Landed 25,000 People in the ER—Here's the Scary Reason Why. Scientists created a new weight-loss drug that protects blood sugar levels and muscle mass.

Novo Nordisk's new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster treatment, an early-stage trial showed, as the drugmaker races to develop ...

Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and ...

If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even more weight loss, since people with diabetes alone tend to lose less on ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, with nearly 90% of participants losing at least 5% of their body weight.